ARTICLE | Financial News
Medivir down on MIV-150 news
April 25, 2002 7:00 AM UTC
Medivir (SSE:MVIR) was off SEK7 (10%) to SEK60 on Thursday after Chiron (CHIR) returned all rights to MVIR's MIV-150 non-nucleoside reverse transcriptase inhibitor (NNRTI). CHIR said that Phase I data...